Up to Date Antiplatelet Therapy in Patients With High Risk of Thrombotic Events and Real Clinical Practice

Rational Pharmacotherapy in Cardiology - Russian Federation
doi 10.20996/1819-6446-2012-8-2-163-167
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Related search

Modern Antiplatelet Therapy of Ischemic Heart Disease Patients With High Risk of Thrombotic Events: Data From Evidence-Based Medicine and Real Practice

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2011English

Combination Therapy of High-Risk Patients in Real Clinical Practice. Results of Synergy Study. Part 1. Antihypertensive Branch

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2017English

Atrial Fibrillation in Patient With High Thrombotic Risk: Which Therapy?

AboutOpen
2018English

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation: Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2009English

Features and Main Problems of Treating Patients With High and Very High Cardiovascular Risk With Statins in Real Clinical Practice (According to the Data of the “PRIORITET” Research)

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2018English

Dual Antiplatelet Therapy After Stenting in All-Comers, ACS Patients and in High Bleeding Risk

English

Application of Antiplatelet and Angioprotective Therapy in Patients With Placental Insufficiency Development Risk Factors

Medical Council
2016English

Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients With Stable Coronary Artery Disease?

Thrombosis and Haemostasis
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy